Inspire Medical Systems (INSP) Stock Analysis & AI Equity Report

Medical - Devices USD Explore free reports

Inspire Medical Systems (INSP) overview

Inspire Medical Systems (INSP) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 912m and operating profit of USD 51.0m; the year-end share price was 92.23 USD and market capitalisation was USD 2,636m. Inspire Medical Systems is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Inspire Medical Systems's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 781mFY 2025
Share price92.23 USDFY 2025 year end
RevenueUSD 912mFY 2025
Operating profitUSD 51.0mFY 2025
Net earningsUSD 145mFY 2025
Market capitalisationUSD 2,636mFY 2025 year end

About Inspire Medical Systems

Inspire Medical Systems develops and commercializes minimally invasive treatments for obstructive sleep apnea. Its Inspire system monitors breathing and delivers mild electrical stimulation to the hypoglossal nerve to help keep the airway open during sleep. Physicians use the system for eligible patients with moderate to severe sleep apnea in the United States, Europe, and Asia.

Generate the Inspire Medical Systems report

Inspire Medical Systems is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Inspire Medical Systems and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Inspire Medical Systems

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.